{
  "meta": {
    "title": "Decoding_Arrhythmias_Sudden_Death",
    "url": "https://brainandscalpel.vercel.app/decoding-arrhythmias-sudden-death-db40827e.html",
    "scrapedAt": "2025-11-29T18:24:40.326Z"
  },
  "questions": [
    {
      "id": 6814,
      "choices": [
        {
          "id": 27225,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Hospital admission </span></span></p>"
        },
        {
          "id": 27226,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Pacemaker implantation </span></span></p>"
        },
        {
          "id": 27227,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Switch lisinopril to amlodipine </span></span></p>"
        },
        {
          "id": 27228,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Reassurance and clinical monitoring</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 84-year-old man presents with fatigue and loss of energy. His ECG is shown. Upon vigorous exercise his heart rate reaches a maximum of 72/min. What is the most appropriate management?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-091643.png\" style=\"height:139px; width:300px\" /></span></span></p>",
      "unique_key": "Q2417207",
      "question_audio": null,
      "question_video": null,
      "map_id": 19761,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Pacemaker implantation</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient has sinus nide dysfunction and he is symptomatic. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Symptomatic bradycardia, especially with an inadequate heart rate response to exercise, often requires pacemaker implantation to improve quality of life and prevent complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Hospital admission:</span></strong><span style=\"font-size:12.0pt\"> Not necessary unless the patient is hemodynamically unstable. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Switching medications:</span></strong><span style=\"font-size:12.0pt\"> Unlikely to address the underlying bradycardia. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Reassurance and monitoring:</span></strong><span style=\"font-size:12.0pt\"> Inadequate for symptomatic bradycardia with potential for adverse outcomes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Treat a patient with symptomatic bradycardia.</span></span></span></p>",
      "correct_choice_id": 27226,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6815,
      "choices": [
        {
          "id": 27229,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Left atrial appendage occlusion </span></span></p>"
        },
        {
          "id": 27230,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Pacemaker implantation </span></span></p>"
        },
        {
          "id": 27231,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Rhythm control </span></span></p>"
        },
        {
          "id": 27232,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">No additional therapy</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 70-year-old man with history of hypertension and stroke has been diagnosed with mildly symptomatic paroxysmal AF. He is currently taking rivaroxaban and metoprolol. What is the most appropriate treatment?</span></span></span></p>",
      "unique_key": "Q9625805",
      "question_audio": null,
      "question_video": null,
      "map_id": 19762,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) Rhythm control</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Early rhythm control (antiarrhythmic drugs or ablation) has been shown to reduce cardiovascular death, stroke, and hospitalization for heart failure or acute coronary syndrome in patients with recent-onset AF and cardiovascular comorbidities.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Left atrial appendage occlusion:</span></strong><span style=\"font-size:12.0pt\"> Indicated for stroke prevention in non-valvular AF but not the primary treatment for rhythm control. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Pacemaker implantation: </span></strong><span style=\"font-size:12.0pt\">Not indicated for paroxysmal AF without symptomatic bradycardia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. No additional therapy:</span></strong><span style=\"font-size:12.0pt\"> Early rhythm control is recommended for this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In patients with recently diagnosed atrial fibrillation and concomitant cardiovascular conditions, early rhythm control (antiarrhythmic drugs or ablation) reduces the primary composite end point of cardiovascular death, stroke, or hospitalization for heart failure or acute coronary syndrome compared with usual care.</span></span></span></p>",
      "correct_choice_id": 27231,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6816,
      "choices": [
        {
          "id": 27233,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Amiodarone </span></span></p>"
        },
        {
          "id": 27234,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Catheter ablation </span></span></p>"
        },
        {
          "id": 27235,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Flecainide </span></span></p>"
        },
        {
          "id": 27236,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;Metoprolol</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 56-year-old man with hypertension presents with acute shortness of breath, hypotension and palpitations. He has jugular venous distention and pulmonary crackles. ECG was done and is shown below. After successful cardioversion, what is the best treatment?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-091936.png\" style=\"height:276px; width:500px\" /></span></span></p>",
      "unique_key": "Q4730483",
      "question_audio": null,
      "question_video": null,
      "map_id": 19763,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Catheter ablation</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical presentation and ECG findings are consistent with atrial flutter, a type of supraventricular tachycardia. Catheter ablation is the most appropriate additional treatment because it offers a high success rate (&gt;95%) and a low complication rate. It is considered the first-line therapy for typical atrial flutter.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Amiodarone: &nbsp;</span></strong><span style=\"font-size:12.0pt\">Antiarrhythmic drug that can be used for atrial flutter, but catheter ablation is more definitive. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Flecainide: </span></strong><span style=\"font-size:12.0pt\">&nbsp;&nbsp;Another antiarrhythmic drug, but catheter ablation is preferred. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Metoprolol: &nbsp;</span></strong><span style=\"font-size:12.0pt\">Beta-blocker, primarily used for rate control, not as effective for rhythm control in atrial flutter. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Catheter ablation is the definitive treatment for typical atrial flutter due to its high success rate and low complication rate.</span></span></span></p>",
      "correct_choice_id": 27234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6817,
      "choices": [
        {
          "id": 27237,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Exercise ECG </span></span></p>"
        },
        {
          "id": 27238,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Implantable loop recorder </span></span></p>"
        },
        {
          "id": 27239,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Holter Monitoring </span></span></p>"
        },
        {
          "id": 27240,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">30-day event monitor</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 26-year-old woman presents with recurrent palpitations lasting 5-15 minutes, occue a few times per month and relieved by rest or deep breathing. The resting ECG is normal. What is the most appropriate diagnostic test?</span></span></p>",
      "unique_key": "Q9383591",
      "question_audio": null,
      "question_video": null,
      "map_id": 19764,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D) 30-day event monitor</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 30-day event monitor is the most appropriate initial test for capturing infrequent and symptomatic arrhythmias (occurring less than daily but occurring over a month). The patient can activate the monitor when symptoms occur, provided that the symptoms last long enough to be captured by the device&#39;s active and retrospective capture. Symptoms that last longer than 1 to 2 minutes are ideally suited for event monitors</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Exercise ECG: </span></strong><span style=\"font-size:12.0pt\">Not indicated for evaluating palpitations occurring at rest. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Implantable loop recorder:</span></strong><span style=\"font-size:12.0pt\"> Reserved for very infrequent or unexplained syncope (which prevents the patient from triggering the devices). Records symptomatic and asymptomatic events (brady/tachy) over a very long period (months to years).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Holter monitoring</span></strong><span style=\"font-size:12.0pt\">: &nbsp;Usually records electrical activity continuously for 24-28 hours and most suited for patients with more frequent symptoms (e.g., daily). </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 30-day event monitor is most appropriate for evaluating patients with palpitations who have symptoms that occur less than daily but frequently over the course of a month.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">An implantable looping event recorder is most appropriate for infrequent or highly symptomatic arrhythmias in which the symptoms might preclude a patient from activating the device, such as syncope.</span></span></span></p>",
      "correct_choice_id": 27240,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6819,
      "choices": [
        {
          "id": 27245,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Brugada syndrome </span></span></p>"
        },
        {
          "id": 27246,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Coronary artery disease </span></span></p>"
        },
        {
          "id": 27247,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Long QT syndrome </span></span></p>"
        },
        {
          "id": 27248,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Vasovagal syncope</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old man presents with recurrent syncope without prodrome. His father died suddenly at age 45. ECG is shown. Physical examination and 2D Echo is normal. What is the most likely diagnosis?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-092311.png\" style=\"height:194px; width:500px\" /></span></span></p>",
      "unique_key": "Q7168209",
      "question_audio": null,
      "question_video": null,
      "map_id": 19766,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Brugada syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of recurrent syncope, family history of sudden death, and the characteristic ECG findings of coved ST-segment elevation in V1-V3 strongly suggest Brugada syndrome, a genetic disorder that predisposes to ventricular arrhythmias and sudden cardiac death.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Coronary artery disease: </span></strong><span style=\"font-size:12.0pt\">Unlikely in a young patient with no risk factors and normal ECG findings. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Long QT syndrome:</span></strong><span style=\"font-size:12.0pt\"> ECG would show a prolonged QT interval, not the Brugada pattern. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Vasovagal syncope:</span></strong><span style=\"font-size:12.0pt\"> Typically has prodromal symptoms (lightheadedness, nausea) and normal ECG.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cardiovascular syncopal events often occur suddenly and usually without a significant prodrome, although chest pain and palpitations may be present.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Causes of cardiovascular syncope include cardiac arrhythmia; coronary artery disease; and structural and obstructive disease, including aortic and pulmonary valve stenosis, obstructive hypertrophic cardiomyopathy, aortic dissection, and cardiac tamponade.</span></span></span></p>",
      "correct_choice_id": 27245,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6820,
      "choices": [
        {
          "id": 27249,
          "text": "<p><span style=\"font-size:11pt;\">Add aspirin</span></p>"
        },
        {
          "id": 27250,
          "text": "<p><span style=\"font-size:11pt;\">Increase metoprolol dose</span></p>"
        },
        {
          "id": 27251,
          "text": "<p><span style=\"font-size:11pt;\">Initiate oral anticoagulation</span></p>"
        },
        {
          "id": 27252,
          "text": "<p><span style=\"font-size:11pt;\">Reassurance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 76-year-old woman presents with palpitations. Her ECG is shown. She is a known diabetic and hypertensive and currently taking metformin and metoprolol. What is the most appropriate management?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-092619.png\" alt=\"\" width=\"500\" height=\"261\"></span></p>",
      "unique_key": "Q3593297",
      "question_audio": null,
      "question_video": null,
      "map_id": 19767,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C) Initiate oral anticoagulation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient has an AF with controlled rate (78/min). Patients with nonvalvular AF and a CHA2DS2-VASc score ≥ 2 in men or ≥ 3 in women should be initiated on oral anticoagulation for stroke prevention (this patient has a CHA2DS2-VASc score of 4).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aspirin: </strong>Insufficient for stroke prevention in high-risk patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Increase metoprolol dosage:</strong> Not necessary as the ventricular rate is controlled.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Reassurance:</strong> Inappropriate as the patient is at high risk for stroke.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In stable patients with atrial fibrillation, the primary goals of therapy are to (1) prevent stroke, (2) control heart rate, (3) minimize or eliminate symptoms, and (4) modify underlying risk factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anticoagulation is indicated for stroke prevention in patients with nonvalvular atrial fibrillation who have a CHA2DS2-VASc score of 2 or greater in men or 3 or greater in women.</span></p>",
      "correct_choice_id": 27251,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6821,
      "choices": [
        {
          "id": 27253,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Cardiac MRI with stress perfusion</span></span></p>"
        },
        {
          "id": 27254,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Electrophysiology (EP) study</span></span></p>"
        },
        {
          "id": 27255,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Implantable cardioverter-defibrillator (ICD)</span></span></p>"
        },
        {
          "id": 27256,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Implantable loop recorder (ILR)</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 42-year-old man presents with palpitations and lightheadedness. He was having significant work pressure over the last 2 weeks and he has not been sleeping well. ECG showed VT and he is successfully cardioverted in the ER. Echocardiogram is normal. What is the most appropriate initial management?</span></span></span></p>",
      "unique_key": "Q8720335",
      "question_audio": null,
      "question_video": null,
      "map_id": 19768,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Cardiac magnetic resonance imaging (MRI) with stress perfusion</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Idiopathic VT typically manifests as palpitations in the third to fifth decades of life, often triggered by stress, emotion, or sleeplessness. Sudden death is rare. </span><span style=\"font-size:12.0pt\">Before making a diagnosis of idiopathic VT, structural heart disease has to be ruled out. First test for structural heart disease would be echocardiogram and in patients with normal echo, cardiac MRI with stress perfusion is recommended to rule out subtle structural abnormalities (e.g., cardiomyopathies) that could be the cause of the arrhythmia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Most idiopathic VT originate in the RV outflow tract, which gives rise to VT that has a LBBB morphology in V1 and an axis that is directed inferiorly, with tall R waves in II, III, and aVF. Idiopathic VT can also arise in the left ventricular outflow tract or in sleeves of myocardium that extend along the aortic root. Left ventricular origin is suspected when leads V1 or V2 have prominent R waves.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. EP study:</span></strong><span style=\"font-size:12.0pt\"> May be indicated later if diagnosis of sustained VT is in doubt or if ablation is being considered (to localize the arrhythmogenic focus).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. ICD:</span></strong><span style=\"font-size:12.0pt\"> May be considered if there is VT + structural heart disease or HF with EF &le; 35%. In idiopathic VT, it is unnecessary. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. ILR:</span></strong> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It would be premature to consider ILR placement before assessment for structural heart disease. An ILR may be valuable to assess rare recurrences of arrhythmia and/or to assess symptoms, but further evaluation is needed first.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cardiac MRI with stress perfusion is a valuable tool for evaluating the underlying cause of VT in patients with structurally normal hearts on echocardiography.</span></span></span></p>",
      "correct_choice_id": 27253,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6822,
      "choices": [
        {
          "id": 27257,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Complete heart block</span></span></p>"
        },
        {
          "id": 27258,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">High-grade atrioventricular block</span></span></p>"
        },
        {
          "id": 27259,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Mobitz type 1 second-degree atrioventricular block</span></span></p>"
        },
        {
          "id": 27260,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Mobitz type 2 second-degree atrioventricular block</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 36-year-old man is evaluated in the emergency department for an irregular heart rhythm. He is otherwise asymptomatic. A representative sample from an ECG rhythm strip is shown. Which of the following abnormalities is seen on this patient&#39;s ECG?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-092929.png\" style=\"height:66px; width:400px\" /></span></span></p>",
      "unique_key": "Q8155966",
      "question_audio": null,
      "question_video": null,
      "map_id": 19769,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) Mobitz type 1 second-degree atrioventricular block</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This ECG demonstrates Mobitz type 1 second-degree (Wenckebach) atrioventricular block, which is characterized electrocardiographically by a PR interval that progressively prolongs until, eventually, the beat is dropped. In the tracing shown, the PR interval widens over the first six beats and no ventricular complex follows the seventh atrial beat.</span></span></span></p>",
      "correct_choice_id": 27259,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6823,
      "choices": [
        {
          "id": 27261,
          "text": "<p><span style=\"font-size:11pt;\">Administer 100% oxygen by NRBM</span></p>"
        },
        {
          "id": 27262,
          "text": "<p><span style=\"font-size:11pt;\">Administer procainamide IV</span></p>"
        },
        {
          "id": 27263,
          "text": "<p><span style=\"font-size:11pt;\">Administer 1 g calcium gluconate IV</span></p>"
        },
        {
          "id": 27264,
          "text": "<p><span style=\"font-size:11pt;\">Unsynchronized defibrillation with 200 J</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 81-year-old man is evaluated in the emergency department for chest pain. During the evaluation, he becomes unresponsive and pulseless. ECG is shown. what is the next best step in the management&nbsp;of&nbsp;this&nbsp;patient?</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093042.png\" alt=\"\" width=\"400\" height=\"187\"></span></p>",
      "unique_key": "Q5620988",
      "question_audio": null,
      "question_video": null,
      "map_id": 19770,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) Unsynchronized defibrillation with 200 J</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This patient is in ventricular fibrillation. Immediate defibrillation&nbsp; is required and treatment should proceed along advanced cardiac life support protocol. Defibrillation in this case should precede administration of oxygen. Medications will not be effective in the absence of circulation.</span></p>",
      "correct_choice_id": 27264,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6824,
      "choices": [
        {
          "id": 27265,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Hypocalcemia</span></span></p>"
        },
        {
          "id": 27266,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Hypokalemia</span></span></p>"
        },
        {
          "id": 27267,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Hypophosphatemia</span></span></p>"
        },
        {
          "id": 27268,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Hypothermia</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following disorders could account for the findings on the rhythm strip of a homeless man who was found unresponsive on the street?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093143.png\" style=\"height:70px; width:400px\" /></span></span></p>",
      "unique_key": "Q2066701",
      "question_audio": null,
      "question_video": null,
      "map_id": 19771,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D) Hypothermia</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypothermia most likely accounts for the findings&nbsp;shown&nbsp;on this electrocardiogram. In hypothermia, all of the electrocardiographic intervals are prolonged, including the PR interval, the QRS complex, the QT interval, and the R-R interval, owing to slowed impulse conduction through potassium channels. In addition, the J point is elevated, producing a characteristic J wave (Osborn wave) that represents distortion of the earliest phase of membrane repolarization. These changes are most prominent in the precordial leads V2&nbsp;through V5. This electrocardiogram demonstrates Osborn waves (arrows).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093206.png\" style=\"height:99px; width:500px\" /></p>",
      "correct_choice_id": 27268,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6825,
      "choices": [
        {
          "id": 27269,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Dual chamber Pacemaker</span></span></p>"
        },
        {
          "id": 27270,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Single chamber pacemaker</span></span></p>"
        },
        {
          "id": 27271,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">CRT device</span></span></p>"
        },
        {
          "id": 27272,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Swan Ganz catheter</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following diagnoses is most consistent with the radiographic findings shown?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-112453.png\" style=\"height:195px; width:400px\" /></span></span></p>",
      "unique_key": "Q5689864",
      "question_audio": null,
      "question_video": null,
      "map_id": 19772,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A) Dual chamber Pacemaker</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The radiographic image shows leads in the right atrium (RA) and right ventricle (RV), consistent with a dual chamber pacemaker. This type of pacemaker is used to provide electrical stimulation to both the atrium and the ventricle, helping to coordinate the heart&#39;s rhythm. This patient in addition has features of pulmonary edema as well. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Single chamber pacemaker:</span></strong><span style=\"font-size:12.0pt\"> A single chamber pacemaker has only one lead, typically in the RV. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. CRT device:</span></strong><span style=\"font-size:12.0pt\"> A CRT device would include an additional lead positioned to pace the left ventricle via the coronary sinus, which is not seen in this image. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Swan Ganz catheter:</span></strong><span style=\"font-size:12.0pt\"> A Swan-Ganz catheter, used for measuring hemodynamic parameters, is not an implantable device and would appear as a different configuration on imaging.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A dual chamber pacemaker has leads placed in both the right atrium and right ventricle. This device is used to maintain coordinated atrial and ventricular pacing in patients with specific types of heart block or other cardiac rhythm disturbances.</span></span></span></p>",
      "correct_choice_id": 27269,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6826,
      "choices": [
        {
          "id": 27273,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Urgent transcutaneous pacing</span></span></p>"
        },
        {
          "id": 27274,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Urgent transvenous pacing</span></span></p>"
        },
        {
          "id": 27275,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Atropine 0.5 mg IV push</span></span></p>"
        },
        {
          "id": 27276,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Emergency defibrillation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old gentleman presents with complaints of dizziness and one episode of syncope. On examination, you notice a pulse rate of around 38/min and blood pressure of approximately 88/56 mmHg. What will be your next step in management?</span></span></p>",
      "unique_key": "Q2701187",
      "question_audio": null,
      "question_video": null,
      "map_id": 19773,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">Atropine 0.5 mg IV push</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is experiencing symptomatic bradycardia with hemodynamic compromise (hypotension and syncope). While the exact cause of the bradycardia is unknown without an ECG, the initial management should focus on increasing the heart rate to stabilize the patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atropine is a parasympatholytic agent that can quickly increase heart rate in cases of symptomatic bradycardia. It is a reasonable first-line treatment in this scenario, as it can be administered rapidly and may be effective if the bradycardia is caused by excessive vagal tone.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Management of bradycardia with a pulse (ACLS) is given below. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Urgent transcutaneous pacing:</strong> While TCP may be necessary if atropine is ineffective or if the bradycardia is due to complete heart block, it is not the initial treatment of choice in this situation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Urgent transvenous pacing:</span></strong><span style=\"font-size:12.0pt\"> Similar to TCP, transvenous pacing is a more definitive treatment but is not the immediate priority in an unstable patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Emergency defibrillation:</span></strong><span style=\"font-size:12.0pt\"> Defibrillation is indicated for ventricular fibrillation or pulseless ventricular tachycardia, not for bradycardia with a pulse.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Symptomatic bradycardia with hemodynamic instability is a medical emergency. Initial treatment as per ACLS protocol is atropine administration. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/picture1.jpg\" style=\"height:859px; width:700px\" /></span></span></span></p>",
      "correct_choice_id": 27275,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6827,
      "choices": [
        {
          "id": 27277,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">PR varying </span></span></p>"
        },
        {
          "id": 27278,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Wide QRS </span></span></p>"
        },
        {
          "id": 27279,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Bundle branch block </span></span></p>"
        },
        {
          "id": 27280,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Defect lies below AV node</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All of the following are true regarding Mobitz II block except?</span></span></span></p>",
      "unique_key": "Q8825356",
      "question_audio": null,
      "question_video": null,
      "map_id": 19774,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) PR varying</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In Mobitz II second-degree heart block, the PR interval remains constant before the dropped beat. This is a key distinguishing feature from Mobitz I (Wenckebach), where the PR interval progressively lengthens before the dropped beat.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Wide QRS:</span></strong><span style=\"font-size:12.0pt\"> This is often present in Mobitz II due to the block occurring below the AV node, affecting the His-Purkinje system.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Bundle branch block:</span></strong><span style=\"font-size:12.0pt\"> Mobitz II is frequently associated with bundle branch block as the block occurs within the bundle branches or more distally in the conduction system.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Defect lies below AV node:</span></strong><span style=\"font-size:12.0pt\"> The conduction defect in Mobitz II is located below the AV node, typically in the His-Purkinje system.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mobitz II second-degree block is associated with a constant PR interval, wide QRS complex and bundle branch block due to the conduction defect located below the AV node.</span></span></span></p>",
      "correct_choice_id": 27277,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6828,
      "choices": [
        {
          "id": 27281,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Carotid sinus massage </span></span></p>"
        },
        {
          "id": 27282,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Adenosine </span></span></p>"
        },
        {
          "id": 27283,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Cardioversion </span></span></p>"
        },
        {
          "id": 27284,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">IV metoprolol</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old male presents with palpitations and giddiness for 2 hours. On arrival, BP is 80/60 mmHg. ECG is shown. What is the next step in management of this patient?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093714.png\" style=\"height:272px; width:500px\" /></span></span></p>",
      "unique_key": "Q4066841",
      "question_audio": null,
      "question_video": null,
      "map_id": 19775,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) Cardioversion</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is presenting with hemodynamic instability (low blood pressure) due to AVNRT (atrioventricular nodal re-entrant tachycardia). In this scenario, the immediate goal is to restore normal sinus rhythm and stabilize the patient. Synchronized cardioversion is the most appropriate initial treatment for hemodynamically unstable tachyarrhythmias.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Carotid sinus massage:</span></strong><span style=\"font-size:12.0pt\"> This maneuver can sometimes terminate AVNRT, but it is not recommended in the setting of hemodynamic instability due to the risk of further complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Adenosine:</span></strong><span style=\"font-size:12.0pt\"> Adenosine is a first-line agent for stable AVNRT, but it is contraindicated in patients with asthma or bronchospasm and may not be effective in cases of hemodynamic instability.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. IV metoprolol:</span></strong><span style=\"font-size:12.0pt\"> Beta-blockers like metoprolol are used for rate control in AVNRT, but they should not be the initial treatment in hemodynamically unstable patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">&lsquo;</span></strong><span style=\"font-size:12.0pt\">If the patient is in shock, shock the patient !&rsquo;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/picture2.jpg\" style=\"height:708px; width:700px\" /></p>",
      "correct_choice_id": 27283,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6829,
      "choices": [
        {
          "id": 27285,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">IV MgSO4 </span></span></p>"
        },
        {
          "id": 27286,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">IV lignocaine </span></span></p>"
        },
        {
          "id": 27287,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">IV amiodarone </span></span></p>"
        },
        {
          "id": 27288,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Defibrillation</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A pregnant lady G2P1L1 currently 37 weeks POG (period of gestation) presented with worsening headache, blurring of vision, reduced perception of fetal movements. On arrival, BP was 200/100 mmHg. ECG is shown. Which of the following is the best management?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-093914.png\" style=\"height:188px; width:400px\" /></span></span></span></p>",
      "unique_key": "Q8364286",
      "question_audio": null,
      "question_video": null,
      "map_id": 19776,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) IV MgSO4</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">ECG shows polymorphic VT (PMVT).<strong> </strong>MgSO4 is the first-line treatment for seizure prevention and treatment in pre-eclampsia and eclampsia. It also has antiarrhythmic properties and can be effective in terminating PMVT, particularly when associated with hypomagnesemia (which is common in pre-eclampsia).</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. IV lignocaine:</span></strong><span style=\"font-size:12.0pt\"> While lidocaine is an antiarrhythmic, it is not effective in PMVT. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. IV amiodarone:</span></strong><span style=\"font-size:12.0pt\"> Amiodarone is effective for monomorphic VT but can prolong QTc interval and potentially can trigger PMVT. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Defibrillation:</span></strong><span style=\"font-size:12.0pt\"> Can be tried in case of unstable PMVT or if the patient is in cardiac arrest.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>&nbsp;</strong><span style=\"font-size:12.0pt\">IV MgSO4 is the treatment of choice for stable PMVT.</span></span></span></p>",
      "correct_choice_id": 27285,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6830,
      "choices": [
        {
          "id": 27289,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">No anticoagulation required</span></span></p>"
        },
        {
          "id": 27290,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Warfarin for 4 weeks</span></span></p>"
        },
        {
          "id": 27291,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Long term Warfarin</span></span></p>"
        },
        {
          "id": 27292,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Anticoagulation is contraindicated</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 44-year-old patient with HCM presents with palpitations over the last 1 week. ECG showed AF. His CHA2DS2-Vasc score is 0. What is the treatment?</span></span></p>",
      "unique_key": "Q5417212",
      "question_audio": null,
      "question_video": null,
      "map_id": 19777,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) Long-term Warfarin (or alternative anticoagulant)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">AF is the most common sustained arrhythmia in patients with HCM. In patients with HCM and AF, anticoagulation is recommended regardless of their CHA2DS2-VASc score. This is because the risk of thromboembolic events (stroke, systemic embolism) is significantly increased in HCM patients with AF, independent of traditional risk factors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While the CHA2DS2-VASc score is a useful tool for assessing stroke risk in general AF population, it is not studied in HCM population and should not be used. Therefore, current guidelines recommend long-term anticoagulation for all HCM patients with AF, even if their CHA2DS2-VASc score is 0.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. No anticoagulation required:</span></strong><span style=\"font-size:12.0pt\"> This is incorrect as anticoagulation is strongly recommended for HCM patients with AF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Warfarin for 4 weeks:</span></strong><span style=\"font-size:12.0pt\"> This is insufficient duration. Long-term anticoagulation is necessary for stroke prevention in HCM patients with AF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Anticoagulation contraindicated:</span></strong><span style=\"font-size:12.0pt\"> This is incorrect. Anticoagulation is indicated for stroke prevention in HCM patients with AF.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><strong> </strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In patients with hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF), long-term anticoagulation is recommended regardless of their CHA2DS2-VASc score due to the increased risk of thromboembolic events.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>",
      "correct_choice_id": 27291,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6831,
      "choices": [
        {
          "id": 27293,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Blood cultures </span></span></p>"
        },
        {
          "id": 27294,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Empiric therapy with cephalexin </span></span></p>"
        },
        {
          "id": 27295,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Pacemaker pocket aspiration </span></span></p>"
        },
        {
          "id": 27296,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">PET/CT scanning</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 71-year-old man with a pacemaker presents with malaise, fatigue, and localized discomfort at the pacemaker site and the appearance is shown in the image. He has no fever, chills, or weight loss. What is the most appropriate management?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-094129.png\" style=\"height:253px; width:300px\" /></span></span></p>",
      "unique_key": "Q8115540",
      "question_audio": null,
      "question_video": null,
      "map_id": 19778,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Blood cultures</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient has signs and symptoms suggestive of a possible cardiac device infection (fever, localized pain/discomfort). Blood cultures are the essential initial step in the evaluation of suspected device infection to identify the causative organism and guide appropriate antibiotic therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Empiric therapy with cephalexin:</span></strong><span style=\"font-size:12.0pt\"> Premature before confirming infection and identifying the causative organism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Pacemaker pocket aspiration:</span></strong><span style=\"font-size:12.0pt\"> Not recommended as it can introduce infection into a previously sterile pocket. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. PET/CT scanning:</span></strong><span style=\"font-size:12.0pt\"> May be helpful later if the diagnosis is unclear, but blood cultures are the priority.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In all patients suspected of having infection of a cardiac implanted electronic device, a minimum of two blood cultures should be drawn from separate sites.</span></span></span></p>",
      "correct_choice_id": 27293,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6832,
      "choices": [
        {
          "id": 27297,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Sick sinus syndrome </span></span></p>"
        },
        {
          "id": 27298,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Pacemaker syndrome </span></span></p>"
        },
        {
          "id": 27299,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Lead displacement </span></span></p>"
        },
        {
          "id": 27300,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Ventricular tachycardia</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 75-year-old patient with long-standing atrial fibrillation (AF) received a VVIR pacemaker. After a few months, he presents with dizziness, fatigue, and visible pulsations in the neck. Which of the following is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q1716418",
      "question_audio": null,
      "question_video": null,
      "map_id": 19779,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Pacemaker syndrome</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pacemaker syndrome</span></strong><span style=\"font-size:12.0pt\"> is a collection of symptoms caused by a loss of atrioventricular (AV) synchrony due to ventricular pacing. This can occur in patients with single-chamber pacemakers (like VVIR) who have underlying sinus node dysfunction (as suggested by the history of AF).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The symptoms of pacemaker syndrome include:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Dizziness and fatigue:</span></strong><span style=\"font-size:12.0pt\"> Due to decreased cardiac output caused by loss of AV synchrony.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Visible neck pulsations:</span></strong><span style=\"font-size:12.0pt\"> Prominent irregular cannon A waves in the JVP due to atrial contraction against a closed tricuspid valve.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Sick sinus syndrome:</span></strong><span style=\"font-size:12.0pt\"> Would not be associated with elevated JVP or cannon &lsquo;a&rsquo; waves. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Lead displacement:</span></strong><span style=\"font-size:12.0pt\"> Lead displacement would likely cause pacing failure or erratic pacing, not the specific symptoms described.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ventricular tachycardia:</span></strong><span style=\"font-size:12.0pt\"> This would present with a rapid, regular heart rhythm and different symptoms (palpitations, chest pain, syncope).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">&nbsp;Pacemaker syndrome is a potential complication of single-chamber ventricular pacing (usually VVIR), and presents with dizziness and syncope due to AV dissociation.</span></span></span></p>",
      "correct_choice_id": 27298,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6833,
      "choices": [
        {
          "id": 27301,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Re-entry </span></span></p>"
        },
        {
          "id": 27302,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Delayed afterdepolarizations (DADs) </span></span></p>"
        },
        {
          "id": 27303,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Early afterdepolarizations (EADs) </span></span></p>"
        },
        {
          "id": 27304,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Enhanced automaticity</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most common mechanism of digitalis-induced ventricular arrhythmias?</span></span></p>",
      "unique_key": "Q9225576",
      "question_audio": null,
      "question_video": null,
      "map_id": 19780,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Delayed afterdepolarizations (DADs)</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Digitalis toxicity leads to an increase in intracellular calcium levels within cardiac myocytes. This calcium overload triggers abnormal electrical impulses known as delayed afterdepolarizations (DADs) that occur during phase 4 of action potential. These DADs can reach a threshold and initiate ectopic beats, leading to various ventricular arrhythmias. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Re-entry:&nbsp;</span></strong><span style=\"font-size:12.0pt\">While re-entry is the <em>most common mechanism for arrhythmias</em> in general, it&#39;s not the primary mechanism for digitalis-induced ventricular arrhythmias.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Early afterdepolarizations (EADs):</span></strong><span style=\"font-size:12.0pt\"> EADs are associated with prolonged repolarization (long QT syndrome), which is not a direct effect of digitalis toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Enhanced automaticity:</span></strong><span style=\"font-size:12.0pt\"> Although digitalis can increase automaticity, it&#39;s not the predominant mechanism; DADs caused by calcium overload play a more significant role.</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Understand that the primary mechanism of digitalis-induced ventricular arrhythmias is delayed afterdepolarizations (DADs) caused by intracellular calcium overload.</span></span></span></p>",
      "correct_choice_id": 27302,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6834,
      "choices": [
        {
          "id": 27305,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Decremental response </span></span></p>"
        },
        {
          "id": 27306,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Sodium-dependent conduction </span></span></p>"
        },
        {
          "id": 27307,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Increased gap junctions </span></span></p>"
        },
        {
          "id": 27308,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Speed of conduction is 1-2 m/s</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following describes the AV node accurately?</span></span></p>",
      "unique_key": "Q4117785",
      "question_audio": null,
      "question_video": null,
      "map_id": 19781,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Decremental response</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrionodal transitional connections exhibit decremental conduction, defined as slowing of conduction with increasingly rapid rates of stimulation. This property of the atrioventricular (AV) node is physiologically important. If a very rapid atrial arrhythmia occurs, the AV node acts as a sort of &ldquo;gatekeeper&rdquo; to the ventricles due to its decremental conduction. Thus, in the case of atrial fibrillation (where atrial rates often exceed 300 beats/min) the ventricular rate never approaches these very rapid rates. Some accessory conduction pathways, in contrast, do not exhibit decremental conduction properties and will very rapidly conduct tachycardias (such as atrial fibrillation) to the ventricles, leading to hemodynamic collapse.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Sodium-dependent conduction:</span></strong><span style=\"font-size:12.0pt\"> The action potential upstroke in the AV node is dependent on the smaller and slower inward Ca2+ current, which is the reason why the upstroke velocity of the action potential is low&mdash;one of the factors responsible for the slow conduction velocity in the AV node.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Increased gap junctions:</span></strong><span style=\"font-size:12.0pt\"> The AV node actually has fewer gap junctions than other parts of the conduction system, contributing to its slower conduction speed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Speed of conduction is 1-2 m/s:</span></strong><span style=\"font-size:12.0pt\"> The conduction speed in the AV node is much slower, around 0.05 m/s (50 mm/s).</span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">AV node acts as a &lsquo;gatekeeper&rsquo; to the ventricles.</span></span></span></p>",
      "correct_choice_id": 27305,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6852,
      "choices": [
        {
          "id": 27376,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">First-degree heart block </span></span></p>"
        },
        {
          "id": 27377,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Mobitz type I, second-degree heart block </span></span></p>"
        },
        {
          "id": 27378,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Mobitz type II, second-degree heart block </span></span></p>"
        },
        {
          "id": 27379,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Complete Heart Block</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">You are seeing Mr. Aravind, a 24-year-old previously healthy athlete, for his routine physical examination. Which of the following rhythms is demonstrated?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-094521.png\" style=\"height:76px; width:400px\" /></span></span></p>",
      "unique_key": "Q3882837",
      "question_audio": null,
      "question_video": null,
      "map_id": 19782,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B) Mobitz type I, second-degree heart block</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The periodic failure of conduction in Mobitz type I block is characterized by a progressively lengthening PR interval, shortening of the RR interval, and a pause that is less than two times the immediately preceding RR interval on the electrocardiogram (ECG). The ECG complex after the pause exhibits a shorter PR interval than that immediately preceding the pause. This ECG pattern most often arises because of decremental conduction of electrical impulses in the atrioventricular node. This rhythm is usually benign and may be seen in very fit athletes due to high vagal tone. This pattern is typically caused by decremental conduction in the atrioventricular (AV) node. It is generally a benign rhythm and can be seen in healthy athletes due to high vagal tone.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. First-degree heart block:</span></strong><span style=\"font-size:12.0pt\"> This has a prolonged but constant PR interval.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Mobitz type II, second-degree heart block:</span></strong><span style=\"font-size:12.0pt\"> This has a constant PR interval with occasional dropped QRS complexes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Type III heart block (complete heart block):</span></strong><span style=\"font-size:12.0pt\"> This has complete dissociation between the atria and ventricles, with no relationship between P waves and QRS complexes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mobitz type I second-degree heart block (Wenckebach) is a relatively benign rhythm often seen in athletes due to high vagal tone.</span></span></span></p>",
      "correct_choice_id": 27377,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6854,
      "choices": [
        {
          "id": 27384,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Multiple pathways </span></span></p>"
        },
        {
          "id": 27385,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Refractory period &gt; 240 ms </span></span></p>"
        },
        {
          "id": 27386,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Inducible AF or AVRT </span></span></p>"
        },
        {
          "id": 27387,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Accessory pathway in the posteroseptal region</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is NOT indicative of high risk in Wolff-Parkinson-White (WPW) syndrome?</span></span></p>",
      "unique_key": "Q2408918",
      "question_audio": null,
      "question_video": null,
      "map_id": 19783,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Refractory period &gt; 240ms</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A <strong>short</strong> refractory period of the accessory pathway (is a high-risk feature in WPW syndrome, as it allows for rapid conduction of impulses from the atria to the ventricles, potentially leading to life-threatening arrhythmia. A refractory period <strong>&gt; 240 ms</strong> indicates a slower conduction pathway and is generally considered <strong>low risk</strong>. Also, exercise TMT demonstrating disappearance of the delta wave and wide QRS at HR &ge; 120 beats/min is also considered low risk since it indicates inability of the accessory pathway to conduct at higher rates.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Multiple pathways:</span></strong><span style=\"font-size:12.0pt\"> The presence of multiple accessory pathways increases the risk of arrhythmias and is a high-risk feature.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Inducible AF or AVRT:</span></strong><span style=\"font-size:12.0pt\"> The ability to induce AF or AV reentrant tachycardia (AVRT) during electrophysiology study indicates a higher risk of spontaneous arrhythmias and is a high-risk feature.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Accessory pathway in the posteroseptal region:</span></strong><span style=\"font-size:12.0pt\"> Poster septal accessory pathways are associated with a higher risk of sudden cardiac death due to their potential to conduct rapidly during AF.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">High risk in WPW = multiple accessory pathways, accessory pathway refractory period &lt; 240ms, inducible AVRT or AF in EPS &amp; shortest RR in AF &le; 250ms.</span></span></span></p>",
      "correct_choice_id": 27385,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6856,
      "choices": [
        {
          "id": 27392,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Adenosine 6 mg IV </span></span></p>"
        },
        {
          "id": 27393,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Synchronized DCC </span></span></p>"
        },
        {
          "id": 27394,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Verapamil 5 mg IV </span></span></p>"
        },
        {
          "id": 27395,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Pain control and IV hydration</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 76-year-old woman with a history of hypertension, COPD, diabetes and osteoporosis presents to the emergency department after a fall, with intense left hip pain, dry mucous membranes, and tachycardia. Her ECG is shown. What is the most appropriate next step?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-095717.png\" style=\"height:258px; width:500px\" /></span></span></span></p>",
      "unique_key": "Q2713815",
      "question_audio": null,
      "question_video": null,
      "map_id": 19784,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D) Pain control and IV hydration</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This rhythm is multifocal atrial tachycardia (MAT), which is easily confused with atrial fibrillation due to its irregularly irregular nature. However, MAT is distinguished by the multiple different P waves present (at least three different P wave morphologies). MAT is classically present in patients with severe pulmonary disease, and is exacerbated in the presence of acute illness. No anticoagulation is needed for MAT, and direct current cardioversion is not efficacious. Some patients respond to the non-dihydropyridine calcium channel blockers (diltiazem and verapamil), and amiodarone has some limited effect. In this patient controlling the underlying cause of her tachycardia (pain and dehydration) is the most appropriate first therapy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Adenosine 6 mg IV:</span></strong><span style=\"font-size:12.0pt\"> Primarily used for supraventricular tachycardia (SVT), not MAT. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Synchronized DCC:</span></strong><span style=\"font-size:12.0pt\"> Not effective for MAT and it is C/I. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Verapamil 5 mg IV:</span></strong><span style=\"font-size:12.0pt\"> Verapamil may be in helpful in some patients with MAT (for rate control) but often unnecessary as treatment of underlying cause is sufficient and the most important. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The initial management of MAT should focus on addressing the underlying causes, such as pain and dehydration in this case. </span></span></span></p>",
      "correct_choice_id": 27395,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6858,
      "choices": [
        {
          "id": 27400,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">It is usually life-threatening. </span></span></p>"
        },
        {
          "id": 27401,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">It relies on enhanced automaticity as a mechanism. </span></span></p>"
        },
        {
          "id": 27402,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">It relies on multiple pathways for conduction from the atrium into the AV node. </span></span></p>"
        },
        {
          "id": 27403,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">It requires systemic anticoagulation for thromboembolic prophylaxis.</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following statements is true regarding the most common form of paroxysmal supraventricular tachycardia (PSVT)?</span></span></span></p>",
      "unique_key": "Q2563783",
      "question_audio": null,
      "question_video": null,
      "map_id": 19785,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) It relies on multiple pathways for conduction from the atrium into the AV node.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most common form of PSVT is atrioventricular nodal reentrant tachycardia (AVNRT). AVNRT is caused by the presence of multiple pathways within or near the AV node, allowing for re-entry circuits to form and sustain the tachycardia. Most forms of AVNRT utilize a slowly conducting AV nodal pathway that is located as a right inferior extension that extends from the compact AV node near the His bundle, inferiorly along the tricuspid valve annulus to the floor of the coronary sinus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. It is usually life-threatening:</span></strong><span style=\"font-size:12.0pt\">&nbsp; AVNRT is usually not life-threatening, though it can cause significant symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. It relies on enhanced automaticity as a mechanism: </span></strong><span style=\"font-size:12.0pt\">&nbsp;AVNRT is a re-entry tachycardia, not caused by enhanced automaticity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. It requires systemic anticoagulation for thromboembolic prophylaxis: </span></strong><span style=\"font-size:12.0pt\">Anticoagulation is not typically required for AVNRT unless there are additional risk factors for thromboembolism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most common form of PSVT is AVNRT, which is caused by re-entry circuits involving multiple pathways within the AV node.</span></span></span></p>",
      "correct_choice_id": 27402,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6859,
      "choices": [
        {
          "id": 27404,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">AF with pre-excitation </span></span></p>"
        },
        {
          "id": 27405,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">AF with LBBB </span></span></p>"
        },
        {
          "id": 27406,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Monomorphic VT </span></span></p>"
        },
        {
          "id": 27407,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Torsades de pointes</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">You are in the emergency department when a 19-year-old woman, Ms. Vidhya, arrives after collapsing during a Sunday marathon. She is unresponsive and pulseless. ECG is shown. Which of the following rhythms is the cause of her cardiac arrest?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-095925.png\" style=\"height:241px; width:500px\" /></span></span></span></p>",
      "unique_key": "Q1956397",
      "question_audio": null,
      "question_video": null,
      "map_id": 19786,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Atrial fibrillation with pre-excitation</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rapid, irregular, broad complex tachycardia (overall rate ~ 200 bpm) with a LBBB morphology (dominant S wave in V1). This could easily be mistaken for AF with LBBB.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">However, the morphology is not typical of LBBB, the rate is too rapid (up to 300 bpm in places, i.e. too rapid to be conducted via the AV node), and there is a subtle beat-to-beat variation in the QRS width which is more typical of WPW (LBBB usually has fixed width QRS complexes).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The rhythm is very difficult to differentiate from polymorphic VT but it does not have the twisting morphology to consider it as Torsades de pointes. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Note: </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Approximately 25% of APs causing preexcitation allow minimum R-to-R intervals of &lt;250 ms during AF and are associated with a higher risk of inducing ventricular fibrillation and sudden death.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pre-excited AF should be treated with electrical cardioversion or IV procainamide or ibutilide, which may terminate the arrhythmia or slow the ventricular rate. <em><u>AV nodal blockers are absolutely C/I.</u></em> </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Atrioventricular nodal reentrant tachycardia: </span></strong><span style=\"font-size:12.0pt\">This is usually a narrow-complex tachycardia, unlike the wide-complex seen in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Monomorphic ventricular tachycardia:</span></strong><span style=\"font-size:12.0pt\"> This has a regular rhythm with similar QRS complexes, unlike the irregular pattern seen here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Torsades de pointes:</span></strong><span style=\"font-size:12.0pt\"> Difficult to differentiate but the given ECG does not have the twisting morphology to consider it as Torsades de pointes. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">AF with preexcitation presents with rapid irregular wide-complex tachycardia and it is lethal. </span></span></span></p>",
      "correct_choice_id": 27404,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6860,
      "choices": [
        {
          "id": 27408,
          "text": "<p><span style=\"font-size:11pt;\">Catheter ablation has a high success rate in common atrial flutter.</span></p>"
        },
        {
          "id": 27409,
          "text": "<p><span style=\"font-size:11pt;\">It is dependent on the cavotricuspid isthmus for conduction.</span></p>"
        },
        {
          "id": 27410,
          "text": "<p><span style=\"font-size:11pt;\">Rate control is often more easily achieved in atrial flutter than in atrial fibrillation.</span></p>"
        },
        {
          "id": 27411,
          "text": "<p><span style=\"font-size:11pt;\">The wave of depolarization propagates anti-clockwise</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following statements regarding the below rhythm is false?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-100045.png\" alt=\"\" width=\"500\" height=\"164\"></span></p>",
      "unique_key": "Q6451254",
      "question_audio": null,
      "question_video": null,
      "map_id": 19787,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Rate control is often more easily achieved in atrial flutter than in atrial fibrillation.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Common or typical right atrial flutter is due to a circuit that revolves counterclockwise in the RA (which produces the characteristic negative sawtooth flutter waves in leads II, III, and aVF and positive P waves in lead V1). The wavefront passes in the cavotricuspid isthmus, where it is susceptible to interruption by catheter ablation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Initial management of atrial flutter is similar to that for AF. Rate control can be achieved with administration of AV nodal–blocking agents, but this is <i>often </i>more difficult than for AF. The risk of thromboembolic events is similar to that<i> </i>associated with AF. Anticoagulation is warranted prior to conversion for episodes more than 48 hours in duration and chronically for patients at increased risk of thromboembolic stroke based on the CHA2DS2-VASc scoring system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a first episode of atrial flutter, conversion to sinus rhythm with no long term anti-arrhythmic drug therapy is reasonable. For recurrent episodes, antiarrhythmic drug therapy with sotalol, dofetilide, disopyramide, and amiodarone may be considered, but &gt;70% of patients experience recurrences. For recurrent episodes of common atrial flutter, catheter ablation<i> of the </i>cavotricuspid isthmus abolishes the arrhythmia in &gt;95% of patients<i> </i>with a low risk of complications.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-100137.png\" alt=\"\" width=\"500\" height=\"497\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Catheter ablation has a high success rate in common atrial flutter:</strong> True. It has &gt; 95% success.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. It is dependent on the cavotricuspid isthmus for conduction:</strong> True. Since the wavefront passes in the cavotricuspid isthmus, where it is susceptible to interruption by catheter ablation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. The wave of depolarization propagates anti-clockwise:</strong> The circuit most commonly revolves in a counterclockwise direction (as viewed looking toward the tricuspid annulus from the ventricular apex), which produces the characteristic negative sawtooth flutter waves in leads II, III, and aVF and positive P waves in lead V1.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Catheter ablation is a highly effective treatment for typical atrial flutter, offering high success rates and a low risk of complications.</span></p>",
      "correct_choice_id": 27410,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6863,
      "choices": [
        {
          "id": 27420,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Incidence increases with age. </span></span></p>"
        },
        {
          "id": 27421,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">More common in women than in men. </span></span></p>"
        },
        {
          "id": 27422,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">It is associated with an increased risk of mortality. </span></span></p>"
        },
        {
          "id": 27423,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">All of the above.</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mr. Sarabesh presents with palpitations. His ECG is shown. Which of the following is false regarding the rhythm?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-100253.png\" style=\"height:121px; width:500px\" /></span></span></p>",
      "unique_key": "Q5913984",
      "question_audio": null,
      "question_video": null,
      "map_id": 19788,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B) More common in women than in men.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The rhythm shows AF and it is the most common sustained arrhythmia and is a major public health problem. Prevalence increases with age, and &gt;95% of AF patients are &gt;60 years of age. The prevalence by age 80 is ~10%. The lifetime risk of developing AF for a 40-year-old male is ~25%. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">AF is slightly more common in men than women</span><span style=\"font-size:12.0pt\"> and more common in whites than blacks. Risk factors for developing AF in addition to age and underlying cardiac disease include hypertension, diabetes mellitus, cardiac disease, obesity, and sleep apnea. AF is associated with a 1.5- to 1.9-fold increased risk of mortality after controlling for underlying heart disease. AF is also associated with a risk of developing HF and vice-versa&mdash;patients with HF have an increased risk of developing AF. AF increases the risk of stroke by 5x and is estimated to be the cause of 25% of strokes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><span style=\"font-size:12.0pt\">True. The incidence of AF <em>increases</em> with age. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><span style=\"font-size:12.0pt\">True. AF is associated with an increased risk of mortality. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong><span style=\"font-size:12.0pt\"> Not all of the above statements are false. Option A and C are true. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Atrial fibrillation is the most common sustained arrhythmia. </span></span></span></p>",
      "correct_choice_id": 27421,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6818,
      "choices": [
        {
          "id": 27241,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Aspiration of the device pocket </span></span></p>"
        },
        {
          "id": 27242,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Pacemaker extraction </span></span></p>"
        },
        {
          "id": 27243,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Topical mupirocin </span></span></p>"
        },
        {
          "id": 27244,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Clinical observation and reassessment</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 68-year-old man with a history of pacemaker insertion presents to you for routine review. You notice the pacemaker site like what is shown in the image. What is the most appropriate additional management?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/22/screenshot-2024-08-22-092200.png\" style=\"height:223px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q7721530",
      "question_audio": null,
      "question_video": null,
      "map_id": 19765,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B) Pacemaker extraction</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Image reveals erythema over the site of pacemaker, which is highly suggestive of a pocket infection. Cardiac device infection requires prompt removal of all hardware, debridement of the pocket, and antibiotic therapy (even if the patient is asymptomatic).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Aspiration:</span></strong><span style=\"font-size:12.0pt\"> Not recommended for diagnostic purposes and can worsen infection. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Topical mupirocin:</span></strong><span style=\"font-size:12.0pt\"> Ineffective for deep pocket infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Option D. Observation:</strong> Inappropriate as the infection can worsen and lead to serious complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prompt device removal and antibiotic therapy is required in cases of suspected or confirmed cardiac device infection.</span></span></span></p>",
      "correct_choice_id": 27242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54253,
      "choices": [
        {
          "id": 216481,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">No anticoagulation</span></span></p>"
        },
        {
          "id": 216482,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Initiate aspirin 325 mg daily </span></span></p>"
        },
        {
          "id": 216483,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Initiate apixaban 5 mg twice daily </span></span></p>"
        },
        {
          "id": 216484,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Initiate warfarin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ms. Kavitha, a 22-year-old woman with rheumatic mitral stenosis develops atrial fibrillation. Her CHA₂DS₂-VASc is 1. Which of the following is the correct approach to stroke prevention?</span></span></p>",
      "unique_key": "Q2161683",
      "question_audio": null,
      "question_video": null,
      "map_id": 25747,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>D) Initiate warfarin</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While Ms. Kavitha&#39;s CHA₂DS₂-VASc score is 1, her rheumatic mitral stenosis places her at high risk for stroke due to AF. Warfarin is the recommended anticoagulant for patients with rheumatic mitral stenosis and AF, as the newer direct-acting oral anticoagulants (DOACs) have not been adequately studied in this population.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. No anticoagulation: </span></strong><span style=\"font-size:12.0pt\">&nbsp;Incorrect, since AF increases the risk of stroke by 20-25x in patients with mitral stenosis. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Initiate aspirin 325 mg daily: </span></strong><span style=\"font-size:12.0pt\">&nbsp;Insufficient for stroke prevention in patients with AF and high risk factors like rheumatic mitral stenosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Initiate apixaban 5 mg twice daily:</span></strong><span style=\"font-size:12.0pt\"> &nbsp;DOACs are not recommended in patients with rheumatic mitral stenosis due to limited data.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong> &nbsp;</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Warfarin is the recommended anticoagulant for stroke prevention in patients with AF and rheumatic mitral stenosis.</span></span></span></p>",
      "correct_choice_id": 216484,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}